loadpatents
name:-0.052038908004761
name:-0.038099050521851
name:-0.0070271492004395
MA; Zhenkun Patent Filings

MA; Zhenkun

Patent Applications and Registrations

Patent applications and USPTO patent grants for MA; Zhenkun.The latest application filed is for "application of rifamycin-quinolizidone conjugate molecule and pharmaceutically acceptable salt thereof".

Company Profile
4.37.46
  • MA; Zhenkun - Jiangsu CN
  • Ma; Zhenkun - Westfield NJ
  • Ma; Zhenkun - Suzhou CN
  • Ma; Zhenkun - Dallas TX
  • Ma; Zhenkun - Gurnee IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Application Of Rifamycin-quinolizidone Conjugate Molecule And Pharmaceutically Acceptable Salt Thereof
App 20220087990 - MA; Zhenkun ;   et al.
2022-03-24
Solid Dispersion Of Rifamycin-nitroimidazole Coupling Molecule And Application Thereof
App 20210338645 - LIU; Yu ;   et al.
2021-11-04
Penam derivatives for treating bacterial infections
Grant 11,040,987 - Ai , et al. June 22, 2
2021-06-22
Antibacterial compounds and uses thereof
Grant 10,981,891 - Upton , et al. April 20, 2
2021-04-20
Penam Derivatives For Treating Bacterial Infections
App 20210070774 - Ai; Huibing ;   et al.
2021-03-11
Use Of Rifamycin-quinolizidone Coupling Molecule
App 20200360520 - Ma; Zhenkun ;   et al.
2020-11-19
Use Of Rifamycin-nitroimidazole Coupling Molecule
App 20200360352 - Ma; Zhenkun ;   et al.
2020-11-19
New Use Of Rifamycin-nitroimidazole Conjugate Molecule
App 20200093807 - MA; Zhenkun ;   et al.
2020-03-26
New Use Of Rifamycin-quinolizidone Dual-action Molecule
App 20200061047 - MA; Zhenkun ;   et al.
2020-02-27
Antibacterial Compounds And Uses Thereof
App 20200039955 - Upton; Anna Marie ;   et al.
2020-02-06
Antibacterial compounds and uses thereof
Grant 10,508,097 - Upton , et al. Dec
2019-12-17
Antibacterial Compounds And Uses Thereof
App 20190071417 - Upton; Anna Marie ;   et al.
2019-03-07
Antibacterial Pharmaceutical Combination and Method for Treating Gram-Negative Bacteria Infections
App 20180353489 - Ma; Zhenkun ;   et al.
2018-12-13
Nitroimidazooxazines and their uses in anti-tubercular therapy
Grant 9,198,913 - Denny , et al. December 1, 2
2015-12-01
Riminophenazines With 2-(heteroaryl) Amino Substituents And Their Anti-microbial Activity
App 20140243327 - Liu; Kai ;   et al.
2014-08-28
Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
Grant 8,716,292 - Liu , et al. May 6, 2
2014-05-06
Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
Grant 8,293,734 - Thompson , et al. October 23, 2
2012-10-23
Antibacterial compounds
Grant 8,163,769 - Anderson , et al. April 24, 2
2012-04-24
Riminophenazines With 2-(heteroaryl)amino Substituents And Their Anti-microbial Activity
App 20120071472 - Liu; Kai ;   et al.
2012-03-22
Nitroimidazooxazines And Their Uses In Anti-tubercular Therapy
App 20120028973 - Denny; William Alexander ;   et al.
2012-02-02
Nitroimidazooxazine And Nitroimidazooxazole Analogues And Their Uses
App 20110028466 - Thompson; Andrew Mark ;   et al.
2011-02-03
Nitroheteroaryl-containing rifamycin derivatives
Grant 7,678,791 - Ding , et al. March 16, 2
2010-03-16
Bicyclic nitroimidazole-substituted phenyl oxazolidinones
Grant 7,666,864 - Ding , et al. February 23, 2
2010-02-23
Bicyclic Nitroimidazole-substituted Phenyl Oxazolidinones
App 20090281088 - Ding; Charles Z. ;   et al.
2009-11-12
Nitroheteroaryl-containing rifamycin derivatives
App 20080139577 - Ding; Charles Z. ;   et al.
2008-06-12
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
Grant 7,265,107 - Li , et al. September 4, 2
2007-09-04
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
Grant 7,256,187 - Li , et al. August 14, 2
2007-08-14
C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes
Grant 7,250,413 - Combrink , et al. July 31, 2
2007-07-31
Rifamycin derivatives effective against drug-resistant microbes
Grant 7,247,634 - Ma , et al. July 24, 2
2007-07-24
Rifamycin imino derivatives effective against drug-resistant microbes
Grant 7,238,694 - Ding , et al. July 3, 2
2007-07-03
Rifamycin derivatives
Grant 7,229,996 - Ma , et al. June 12, 2
2007-06-12
(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions
Grant 7,226,931 - Ding , et al. June 5, 2
2007-06-05
6-O-substituted ketolides having antibacterial activity
Grant RE39,591 - Or , et al. April 24, 2
2007-04-24
Spiro-rifamycin derivatives targeting RNA polymerase
Grant 7,202,246 - Ma , et al. April 10, 2
2007-04-10
6-O-substituted erythromycin derivatives having improved gastrointestinal tolerance
App 20060166906 - Ma; Zhenkun ;   et al.
2006-07-27
Oxolide antibacterials
Grant 6,998,390 - Ma , et al. February 14, 2
2006-02-14
Tricyclic macrolide antibacterial compounds
Grant 6,992,069 - Gu , et al. January 31, 2
2006-01-31
Rifamycin derivatives
App 20060019985 - Ma; Zhenkun ;   et al.
2006-01-26
(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions
App 20060019986 - Ding; Charles Z. ;   et al.
2006-01-26
Spiro-rifamycin derivatives targeting RNA polymerase
App 20050277633 - Ma, Zhenkun ;   et al.
2005-12-15
Antibacterial compounds with improved pharmacokinetic profiles
App 20050267054 - Clark, Richard F. ;   et al.
2005-12-01
Rifamycin derivatives effective against drug-resistant microbes
App 20050261262 - Ma, Zhenkun ;   et al.
2005-11-24
C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes
App 20050256096 - Combrink, Keith ;   et al.
2005-11-17
Rifamycin imino derivatives effective against drug-resistant microbes
App 20050209210 - Ding, Charles Z. ;   et al.
2005-09-22
Anti-infective agents useful against multidrug-resistant strains of bacteria
Grant 6,946,446 - Ma , et al. September 20, 2
2005-09-20
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
App 20050203076 - Li, Jing ;   et al.
2005-09-15
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
App 20050203085 - Li, Jing ;   et al.
2005-09-15
11-deoxy azalide antibacterials
Grant 6,933,283 - Clark , et al. August 23, 2
2005-08-23
Fluorescent probes for ribosomes and method of use
App 20050118624 - Ma, Zhenkun ;   et al.
2005-06-02
Macrolide antibacterial compounds
Grant 6,831,068 - Clark , et al. December 14, 2
2004-12-14
Antibacterial compounds
Grant 6,818,654 - Anderson , et al. November 16, 2
2004-11-16
9a-azalides with antibacterial activity
Grant 6,764,996 - Or , et al. July 20, 2
2004-07-20
Antibacterial compounds
App 20040072817 - Anderson, David ;   et al.
2004-04-15
Antibacterial compounds with improved pharmacokinetic profiles
App 20040033970 - Clark, Richard F. ;   et al.
2004-02-19
Tricyclic macrolide antibacterial compounds
App 20040029818 - Gu, Yu-Gui ;   et al.
2004-02-12
9-Oxime macrolide antibacterials
App 20040014691 - Searle, Xenia Beebe ;   et al.
2004-01-22
Macrolide antibacterial compounds
App 20040014687 - Ma, Zhenkun ;   et al.
2004-01-22
11-Deoxy azalide antibacterials
App 20040014953 - Clark, Richard ;   et al.
2004-01-22
Oxolide antibacterials
App 20040014688 - Ma, Zhenkun ;   et al.
2004-01-22
Macrolides with activity against methicillin-resistant staphylococcus aureus
App 20040014690 - Ma, Zhenkun ;   et al.
2004-01-22
Antibacterial compounds with activity against penicillin-resistant streptococcus pneumoniae
App 20040009932 - Phelan, Kathleen ;   et al.
2004-01-15
Macrolide antibacterial compounds
App 20040009931 - Clark, Richard ;   et al.
2004-01-15
9-amino erythromycin derivatives with antibacterial activity
Grant 6,667,338 - Ma , et al. December 23, 2
2003-12-23
Antibacterial compounds
App 20030232818 - Anderson, David ;   et al.
2003-12-18
Antibacterial compounds with improved pharmacokinetic profiles
App 20030207820 - Clark, Richard F. ;   et al.
2003-11-06
Macrolide antibacterial compounds
App 20030171308 - Clark, Richard ;   et al.
2003-09-11
Macrolides with activity against methicillin-resistant staphylococcus aureus
App 20030162729 - Ma, Zhenkun ;   et al.
2003-08-28
6-O-alkyl-2-nor-2-substituted ketolide derivatives
Grant 6,569,836 - Phan , et al. May 27, 2
2003-05-27
C-2 modified erythromycin derivatives
App 20020193320 - Ma, Zhenkun ;   et al.
2002-12-19
9-Amino erythromycin derivatives with antibacterial activity
App 20020142973 - Ma, Zhenkun ;   et al.
2002-10-03
9-amino erythromycin derivatives with antibacterial activity
App 20020132782 - Ma, Zhenkun ;   et al.
2002-09-19
6-O-alkyl-2-nor-2-substituted ketolide derivatives
App 20020103140 - Phan, Ly Tam ;   et al.
2002-08-01
6-O-carbamate ketolide derivatives
Grant 6,420,535 - Phan , et al. July 16, 2
2002-07-16
C-2 modified erythromycin derivatives
Grant 6,355,620 - Ma , et al. March 12, 2
2002-03-12
Anti-infective agents useful against multidrug-resistant strains of bacteria
App 20020019355 - Ma, Zhenkun ;   et al.
2002-02-14
6-O-substituted erythromycin compounds and method for making same
Grant 6,075,011 - Or , et al. June 13, 2
2000-06-13
6-O-substituted antibacterial erythromycin ketolides and methods of making
Grant 6,075,133 - Or , et al. June 13, 2
2000-06-13
6-O-substituted macrolides having antibacterial activity
Grant 6,054,435 - Or , et al. April 25, 2
2000-04-25
6-0-Substituted antibacterial erythromycin ketolides and methods of making
Grant 6,028,181 - Or , et al. February 22, 2
2000-02-22
6-O-substituted ketolides having antibacterial activity
Grant 5,866,549 - Or , et al. February 2, 1
1999-02-02
Quinolizinone type compounds
Grant 5,599,816 - Chu , et al. February 4, 1
1997-02-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed